The NGF-driven upregulation of smad7, an inhibitory component of TGFβ1 pathway, and VEGF/cyr61 deserve further investigation, as opening to alternative approaches in counteracting fibrosis, especially for fibrotic eye diseases. The gene discussed is CCN1; the disease is eye disorder.